Skip to main content
Year archive

BioInvent International — 2018 filings

All 43 regulatory filings released by BioInvent International (BINV) in 2018, sourced directly from the official regulator.

43 Filings
2018 Period
2018 filings (43)
Filing Released Lang
BioInvent signs manufacturing agreement with U.S. cell therapy company
Regulatory Filings
2018-11-20 English
BioInvent ingår tillverkningsavtal med amerikanskt cellterapiföretag
Regulatory Filings
2018-11-20 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-11-12 English
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-10-24 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report 9M 2018
2018-10-24 English
BioInvent ingår licens- och tillverkningsavtal med CardioVax avseende utveckling av orticumab
M&A Activity
2018-09-27 Swedish
BioInvent signs licensing and manufacturing agreement with CardioVax for the development of orticumab
Regulatory Filings
2018-09-27 English
BioInvent receives notice of allowance from U.S. Patent and Trademark Office relevant to its F.I.R.S.T.TM platform
Regulatory Filings
2018-09-26 English
BioInvent har erhållit ett besked om godkännande från det amerikanska patentverket som är relevant för bolagets plattform F.I.R.S.T.™
Regulatory Filings
2018-09-26 Swedish
BioInvents partner Oxurion rekryterar första patienten i en klinisk fas 2-studie som utvärderar THR-317 för behandling av idiopatisk MacTel 1
Regulatory Filings
2018-09-20 Swedish
BioInvent meddelar att den första patienten doserats i en fas I/IIa-studie med BI-1206 i kombination med rituximab vid non-Hodgkins lymfom
Regulatory Filings
2018-09-04 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H2 2018
2018-07-24 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report H1 2018
2018-07-24 English
BioInvent ingår produktionsavtal med ITBMed
Regulatory Filings
2018-07-23 Swedish
BioInvents partner ThromboGenics rapporterar topline-data från dag 150 i fas l/ll-studie av THR-317 hos patienter med diabetiskt makulaödem
Regulatory Filings
2018-07-19 Swedish
FDA-godkännande innebär att BioInvent kan öppna amerikanska studiesites i den nya fas I/IIa-studien med BI-1206
Regulatory Filings
2018-07-12 Swedish
Det japanska patentverket avser bevilja BioInvent patent relevant för bolagets plattform F.I.R.S.T.TM
Regulatory Filings
2018-07-09 Swedish
The Japanese patent office intends to grant BioInvent patent relevant to its F.I.R.S.T.TM platform
Regulatory Filings
2018-07-09 English
Ändring av antalet aktier och röster i BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements
2018-05-31 Swedish
Change in the number of shares and votes in BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements
2018-05-31 English
BioInvent ready to start a Phase I/IIa study of BI-1206 in combination with rituximab in patients with non-Hodgkin lymphoma
Regulatory Filings
2018-05-09 English
BioInvent redo att inleda en fas I/IIa-studie med BI-1206 i kombination med rituximab i patienter med non-Hodgkins lymfom
Earnings Release FY 2018
2018-05-09 Swedish
BioInvent samarbetspartner ThromboGenics startar kombinationsstudie i fas II med läkemedelskandidaten THR-318 och ranibizumab
Regulatory Filings
2018-04-27 Swedish
BioInvent’s collaboration partner ThromboGenics initiates a Phase II combination study with the drug candidate THR-317 and ranibizumab
Regulatory Filings
2018-04-27 English
Resolutions at BioInvent’s Annual General Meeting 2018
AGM Information
2018-04-24 English
Beslut på BioInvents årsstämma 2018
AGM Information
2018-04-24 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-24 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report Q1 2018
2018-04-24 English
BioInvent rekryterar Martin Welschof som ny vd
Board/Management Information
2018-04-12 Swedish
BioInvent recruits Martin Welschof as new CEO
Board/Management Information
2018-04-12 English
Major Shareholding Notification 2018
Major Shareholding Notification
2018-04-05 English
BioInvents partner ThromboGenics presenterar initiala data från en fas l/ll-studie av THR-317 hos patienter med diabetiskt makulaödem
Regulatory Filings
2018-04-04 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-03 Swedish
Annual Report 2017
Annual Report FY 2017
2018-04-03 English
Ändring av antalet aktier och röster i BioInvent International AB
Share Issue/Capital Change
2018-03-29 Swedish
Major Shareholding Notification 2018
Major Shareholding Notification
2018-03-28 English
BioInvent har genomfört en riktad nyemission om cirka 85 miljoner kronor
Capital/Financing Update
2018-03-28 Swedish
BioInvent avser att genomföra riktad nyemission
Capital/Financing Update
2018-03-27 Swedish
Kallelse till årsstämma i BioInvent International AB
AGM Information
2018-03-21 Swedish
Earnings Release 2017
Earnings Release FY 2017
2018-01-30 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q4 2017
2018-01-30 English
European Patent Office intends to grant BioInvent patent relevant to its F.I.R.S.T.TM platform
Regulatory Filings
2018-01-17 English
Europapatentverket avser bevilja BioInvent patent relevant för bolagets plattform F.I.R.S.T.TM
Regulatory Filings
2018-01-17 Swedish